Prior Authorization Leads to Decreases, Delays in Filling Heart Failure Medications

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, March 13, 2026 -- For patients with heart failure, prior authorization is associated with reduced and delayed filling of prescriptions for angiotensin receptor neprilysin inhibitors (ARNIs) and sodium glucose cotransporter 2 inhibitors (SGLT2is), according to a study published in the Feb. 1 issue of JACC: Advances.

Amrita Mukhopadhyay, M.D., from NYU Grossman School of Medicine in New York City, and colleagues conducted a retrospective cohort study using electronic health record, pharmacy fill, and neighborhood-level data to examine whether prior authorizations were associated with delayed or decreased filling for ARNIs and SGLT2is among 2,183 patients with heart failure.

Overall, 12.2 and 14.3 percent of 1,243 and 1,150 patients, respectively, had a prior authorization requirement for an ARNI or SGLT2i. Prior authorization was required for patients who tended to be younger, identify as non-Hispanic Black or Hispanic, have non-Medicare insurance, and have fewer comorbidities. In weighted models, patients requiring prior authorization took 3.03 and 6.75 times longer to fill ARNI and SGLT2i prescriptions, respectively, and were 2.23 times more likely to never fill prescriptions for an SGLT2i.

"Our results suggest that prior authorization may be doing harm when it comes to guideline-recommended medications with no generic alternatives," Mukhopadhyay said in a statement. "While these policies are meant to control health care costs by steering patients toward lower-priced alternatives, they may instead be keeping people with heart failure from timely access to lifesaving treatments."

One author disclosed financial ties to Abbott Vascular, Philips, and Siemens.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-14 01:36

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords